ETS-related gene (ERG) expression as a predictor of oncological outcomes in patients with high-grade prostate cancer treated with primary androgen deprivation therapy: a cohort study

OBJECTIVES: To determine whether ETS-related gene (ERG) expression can be used as a biomarker to predict biochemical recurrence and prostate cancer-specific death in patients with high Gleason grade prostate cancer treated with androgen deprivation therapy (ADT) as monotherapy. METHODS: A multicentr...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezk, Mark, Chandra, Ashish, Addis, Daniel, Møller, Henrik, Youssef, Mina, Dasgupta, Prokar, Yamamoto, Hide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429920/
https://www.ncbi.nlm.nih.gov/pubmed/30852544
http://dx.doi.org/10.1136/bmjopen-2018-025161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429920/
https://www.ncbi.nlm.nih.gov/pubmed/30852544
http://dx.doi.org/10.1136/bmjopen-2018-025161

Ejemplares similares